Portola Pharmaceuticals Inc

CIK 1269021 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Portola Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Jul 13, 202015-12B0001104659-20-082933
Jul 7, 202040001225208-20-009616
Jul 2, 202025-NSE0001354457-20-000313
Jul 2, 202040001209191-20-040380
Jul 2, 202040001209191-20-040364
Jul 2, 2020S-8 POS0001104659-20-080266
Jul 2, 2020POSASR0001104659-20-080272
Jul 2, 2020S-8 POS0001104659-20-080269
Jul 2, 202040001209191-20-040317
Jul 2, 202040001209191-20-040307
Jul 2, 202040001209191-20-040326
Jul 2, 202040001209191-20-040332
Jul 2, 202040001209191-20-040341
Jul 2, 2020S-8 POS0001104659-20-080267
Jul 2, 202040001209191-20-040311
Jul 2, 202040001209191-20-040321
Jul 2, 2020S-8 POS0001104659-20-080260
Jul 2, 2020S-8 POS0001104659-20-080268
Jul 2, 202040001209191-20-040295
Jul 2, 202040001209191-20-040301
Jul 2, 2020S-8 POS0001104659-20-080264
Jul 2, 20208-K0001104659-20-080238
Jul 2, 202040001209191-20-040346
Jul 2, 2020SC 14D9/A0001104659-20-080093
Jul 2, 2020S-8 POS0001104659-20-080256